Real-world Clinical Effectiveness and Safety of Vedolizumab and Adalimumab in Biologic-naive Patients With Crohn’s Disease
Andrés Yarur(Cedars-Sinai Medical Center), Gerassimos J. Mantzaris(European CanCer Organisation), Neil R. Brett(McGill University), Shashi Adsul(Takeda (United States)), Marielle Bassel, Brian Bressler(University of British Columbia), Pravin Kamble(Takeda (United States))
Cited by 3
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Rates of New or Missed Colorectal Cancers After Colonoscopy and Their Risk Factors: A Population-Based Analysis
|Gastroenterology|2007|627
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
|Gastroenterology|2015|478